Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 1997;96:2317-2324

This Article
Right arrow Full Text
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nossuli, T. O.
Right arrow Articles by Lefer, A. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nossuli, T. O.
Right arrow Articles by Lefer, A. M.

(Circulation. 1997;96:2317-2324.)
© 1997 American Heart Association, Inc.


Articles

Peroxynitrite Reduces Myocardial Infarct Size and Preserves Coronary Endothelium After Ischemia and Reperfusion in Cats

Tareck O. Nossuli, BS; Reid Hayward, PhD; Rosario Scalia, MD, PhD; ; Allan M. Lefer, PhD

From the Department of Physiology, Jefferson Medical College, Thomas Jefferson University, Philadelphia, Pa.

Correspondence to Dr Allan M. Lefer, Department of Physiology, Jefferson Medical College, 1020 Locust St, Philadelphia, PA 19107.

Background Peroxynitrite (ONOO-) is purported to exert cytotoxic effects at high doses. However, physiologically relevant concentrations of ONOO- inhibit polymorphonuclear neutrophil (PMN) adhesion to the endothelium and attenuate PMN-mediated contractile dysfunction in isolated perfused rat hearts. We are unaware of any reports in vivo showing effects of peroxynitrite in myocardial ischemia and reperfusion (MI/R). Thus, the purpose of this study was to examine the in vivo effects of a physiologically relevant concentration of ONOO- (1 µmol/L) in a feline model of MI/R injury.

Methods and Results ONOO- (1 µmol/L) or its vehicle (0.9% NaCl at pH 8.4) was infused intraventricularly, starting 10 minutes before reperfusion in cats subjected to 90 minutes of myocardial ischemia and 4.5 hours of reperfusion. ONOO--treated cats demonstrated marked attenuation of cardiac necrosis after MI/R compared with cats receiving only vehicle (P<.001). Moreover, vasorelaxation of ischemic-reperfused left anterior descending (LAD) coronary artery rings in response to the endothelium-dependent dilators acetylcholine and A23187 was greater in rings isolated from ONOO--treated MI/R cats compared with MI/R cats receiving only vehicle, indicating that postreperfusion coronary vascular endothelial function was preserved by ONOO-. ONOO- also significantly reduced adherence of neutrophils to the ischemic-reperfused LAD coronary endothelium. Immunohistochemical localization of P-selectin was also significantly attenuated in hearts from ONOO--infused MI/R cats.

Conclusions These data suggest that physiologically relevant concentrations of ONOO- exert significant cardioprotective and vasculoprotective effects in MI/R in cats, at least partially by attenuating PMN-endothelium interactions.


Key Words: neutrophils • vasorelaxation • leukocytes • endothelium • endothelium-derived factors • ischemia • reperfusion




This article has been cited by other articles:


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
K. Kupai, C. Csonka, V. Fekete, L. Odendaal, J. van Rooyen, D. W. Marais, T. Csont, and P. Ferdinandy
Cholesterol diet-induced hyperlipidemia impairs the cardioprotective effect of postconditioning: role of peroxynitrite
Am J Physiol Heart Circ Physiol, November 1, 2009; 297(5): H1729 - H1735.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
R. R. Lamberts, G. Onderwater, N. Hamdani, M. J. A. Vreden, J. Steenhuisen, E. C. Eringa, S. A. Loer, G. J.M. Stienen, and R. A. Bouwman
Reactive Oxygen Species-Induced Stimulation of 5'AMP-Activated Protein Kinase Mediates Sevoflurane-Induced Cardioprotection
Circulation, September 15, 2009; 120(11_suppl_1): S10 - S15.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
K. Kaiserova, X.-L. Tang, S. Srivastava, and A. Bhatnagar
Role of Nitric Oxide in Regulating Aldose Reductase Activation in the Ischemic Heart
J. Biol. Chem., April 4, 2008; 283(14): 9101 - 9112.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
A. Kunz, L. Park, T. Abe, E. F. Gallo, J. Anrather, P. Zhou, and C. Iadecola
Neurovascular Protection by Ischemic Tolerance: Role of Nitric Oxide and Reactive Oxygen Species
J. Neurosci., July 4, 2007; 27(27): 7083 - 7093.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
M. V. Cohen, X.-M. Yang, and J. M. Downey
Nitric oxide is a preconditioning mimetic and cardioprotectant and is the basis of many available infarct-sparing strategies
Cardiovasc Res, May 1, 2006; 70(2): 231 - 239.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
A. A. El-Menyar
The Resuscitation Outcome: Revisit the Story of the Stony Heart
Chest, October 1, 2005; 128(4): 2835 - 2846.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
R. Schulz, M. Kelm, and G. Heusch
Nitric oxide in myocardial ischemia/reperfusion injury
Cardiovasc Res, February 15, 2004; 61(3): 402 - 413.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
K. Laude, J. Favre, C. Thuillez, and V. Richard
NO produced by endothelial NO synthase is a mediator of delayed preconditioning-induced endothelial protection
Am J Physiol Heart Circ Physiol, June 1, 2003; 284(6): H2053 - H2060.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
K. Laude, C. Thuillez, and V. Richard
Peroxynitrite triggers a delayed resistance of coronary endothelial cells against ischemia-reperfusion injury
Am J Physiol Heart Circ Physiol, October 1, 2002; 283(4): H1418 - H1423.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
F. H. Khadour, D. Panas, P. Ferdinandy, C. Schulze, T. Csont, M. M. Lalu, S. M. Wildhirt, and R. Schulz
Enhanced NO and superoxide generation in dysfunctional hearts from endotoxemic rats
Am J Physiol Heart Circ Physiol, September 1, 2002; 283(3): H1108 - H1115.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
E. Iraculis, A. Cequier, J. A. Gomez-Hospital, M. Sabate, J. Mauri, E. Fernandez-Nofrerias, B. Garcia del Blanco, F. Jara, and E. Esplugas
Early dysfunction and long-term improvement in endothelium-dependent vasodilation in the infarct-related artery after thrombolysis
J. Am. Coll. Cardiol., July 17, 2002; 40(2): 257 - 265.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
B. ZINGARELLI, P. W. HAKE, Z. YANG, M. O'CONNOR, A. DENENBERG, and H. R. WONG
Absence of inducible nitric oxide synthase modulates early reperfusion-induced NF-{kappa}B and AP-1 activation and enhances myocardial damage
FASEB J, March 1, 2002; 16(3): 327 - 342.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
Y. Zhang, J. W. Bissing, L. Xu, A. J. Ryan, S. M. Martin, F. J. Miller Jr, K. C. Kregel, G. R. Buettner, and R. E. Kerber
Nitric oxide synthase inhibitors decrease coronary sinus-free radical concentration and ameliorate myocardial stunning in an ischemia-reperfusion model
J. Am. Coll. Cardiol., August 1, 2001; 38(2): 546 - 554.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
P. Ferdinandy and R. Schulz
Peroxynitrite: Toxic or Protective in the Heart?
Circ. Res., February 2, 2001; 88 (2): e12 - e13.
[Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
P. Liu, B. Xu, J. Quilley, and P. Y.-K. Wong
Peroxynitrite attenuates hepatic ischemia-reperfusion injury
Am J Physiol Cell Physiol, December 1, 2000; 279(6): C1970 - C1977.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
N. S. Dhalla, A. B. Elmoselhi, T. Hata, and N. Makino
Status of myocardial antioxidants in ischemia-reperfusion injury
Cardiovasc Res, August 18, 2000; 47(3): 446 - 456.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
J. Vinten-Johansen
Physiological Effects of Peroxynitrite : Potential Products of the Environment
Circ. Res., August 4, 2000; 87(3): 170 - 172.
[Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
X. L. Ma, F. Gao, G.-L. Liu, B. L. Lopez, T. A. Christopher, J. M. Fukuto, D. A. Wink, and M. Feelisch
Opposite effects of nitric oxide and nitroxyl on postischemic myocardial injury
PNAS, December 7, 1999; 96(25): 14617 - 14622.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
K. B. Sandau, D. Callsen, and B. Brüne
Protection against Nitric Oxide-Induced Apoptosis in Rat Mesangial Cells Demands Mitogen-Activated Protein Kinases and Reduced Glutathione
Mol. Pharmacol., October 1, 1999; 56(4): 744 - 751.
[Abstract] [Full Text]


Home page
Cardiovasc ResHome page
R. S Ronson, M. Nakamura, and J. Vinten-Johansen
The cardiovascular effects and implications of peroxynitrite
Cardiovasc Res, October 1, 1999; 44(1): 47 - 59.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
R. D Rakhit, R. J Edwards, and M. S Marber
Nitric oxide, nitrates and ischaemic preconditioning
Cardiovasc Res, August 15, 1999; 43(3): 621 - 627.
[Full Text] [PDF]


Home page
Cardiovasc ResHome page
I. Tritto and G. Ambrosio
Spotlight on microcirculation: an update
Cardiovasc Res, June 1, 1999; 42(3): 600 - 606.
[Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
T. O. Nossuli, R. Hayward, D. Jensen, R. Scalia, and A. M. Lefer
Mechanisms of cardioprotection by peroxynitrite in myocardial ischemia and reperfusion injury
Am J Physiol Heart Circ Physiol, August 1, 1998; 275(2): H509 - H519.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
B. M. Matata and M. Galinanes
Peroxynitrite Is an Essential Component of Cytokines Production Mechanism in Human Monocytes through Modulation of Nuclear Factor-kappa B DNA Binding Activity
J. Biol. Chem., January 11, 2002; 277(3): 2330 - 2335.
[Abstract] [Full Text] [PDF]